<!-- html table generated in R 3.5.3 by xtable 1.8-4 package -->
<!-- Wed Jun 12 00:03:21 2019 -->
<table border=1>
<tr> <th>  </th> <th> GOBPID </th> <th> Pvalue </th> <th> OddsRatio </th> <th> ExpCount </th> <th> Count </th> <th> Size </th> <th> Term </th> <th> Genes </th>  </tr>
  <tr> <td> 1 </td> <td align="center"> GO:0001172 </td> <td align="right"> 0.00 </td> <td align="right"> Inf </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   1 </td> <td> transcription, RNA-templated </td> <td> RMRP </td> </tr>
  <tr> <td> 2 </td> <td align="center"> GO:0015728 </td> <td align="right"> 0.00 </td> <td align="right"> Inf </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   1 </td> <td> mevalonate transport </td> <td> SLC16A1 </td> </tr>
  <tr> <td> 3 </td> <td align="center"> GO:0051780 </td> <td align="right"> 0.00 </td> <td align="right"> Inf </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   1 </td> <td> behavioral response to nutrient </td> <td> SLC16A1 </td> </tr>
  <tr> <td> 4 </td> <td align="center"> GO:1903704 </td> <td align="right"> 0.00 </td> <td align="right"> Inf </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   1 </td> <td> negative regulation of production of siRNA involved in RNA interference </td> <td> RMRP </td> </tr>
  <tr> <td> 5 </td> <td align="center"> GO:2000452 </td> <td align="right"> 0.00 </td> <td align="right"> Inf </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   1 </td> <td> regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation </td> <td> RIPK3 </td> </tr>
  <tr> <td> 6 </td> <td align="center"> GO:0010142 </td> <td align="right"> 0.00 </td> <td align="right"> 798.00 </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   2 </td> <td> farnesyl diphosphate biosynthetic process, mevalonate pathway </td> <td> HMGCS2 </td> </tr>
  <tr> <td> 7 </td> <td align="center"> GO:0035697 </td> <td align="right"> 0.00 </td> <td align="right"> 798.00 </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   2 </td> <td> CD8-positive, alpha-beta T cell extravasation </td> <td> RIPK3 </td> </tr>
  <tr> <td> 8 </td> <td align="center"> GO:0035879 </td> <td align="right"> 0.00 </td> <td align="right"> 798.00 </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   2 </td> <td> plasma membrane lactate transport </td> <td> SLC16A1 </td> </tr>
  <tr> <td> 9 </td> <td align="center"> GO:0060545 </td> <td align="right"> 0.00 </td> <td align="right"> 798.00 </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   2 </td> <td> positive regulation of necroptotic process </td> <td> RIPK3 </td> </tr>
  <tr> <td> 10 </td> <td align="center"> GO:0006090 </td> <td align="right"> 0.00 </td> <td align="right"> 25.50 </td> <td align="right"> 0.09 </td> <td align="right">   2 </td> <td align="right">  69 </td> <td> pyruvate metabolic process </td> <td> PFKFB1, SLC16A1 </td> </tr>
  <tr> <td> 11 </td> <td align="center"> GO:1900368 </td> <td align="right"> 0.00 </td> <td align="right"> 398.96 </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   3 </td> <td> regulation of RNA interference </td> <td> RMRP </td> </tr>
  <tr> <td> 12 </td> <td align="center"> GO:2000407 </td> <td align="right"> 0.00 </td> <td align="right"> 398.96 </td> <td align="right"> 0.00 </td> <td align="right">   1 </td> <td align="right">   3 </td> <td> regulation of T cell extravasation </td> <td> RIPK3 </td> </tr>
  <tr> <td> 13 </td> <td align="center"> GO:0006003 </td> <td align="right"> 0.01 </td> <td align="right"> 265.95 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   4 </td> <td> fructose 2,6-bisphosphate metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 14 </td> <td align="center"> GO:0015727 </td> <td align="right"> 0.01 </td> <td align="right"> 265.95 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   4 </td> <td> lactate transport </td> <td> SLC16A1 </td> </tr>
  <tr> <td> 15 </td> <td align="center"> GO:0051351 </td> <td align="right"> 0.01 </td> <td align="right"> 265.95 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   4 </td> <td> positive regulation of ligase activity </td> <td> RIPK3 </td> </tr>
  <tr> <td> 16 </td> <td align="center"> GO:0070235 </td> <td align="right"> 0.01 </td> <td align="right"> 265.95 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   4 </td> <td> regulation of activation-induced cell death of T cells </td> <td> RIPK3 </td> </tr>
  <tr> <td> 17 </td> <td align="center"> GO:0033133 </td> <td align="right"> 0.01 </td> <td align="right"> 199.45 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   5 </td> <td> positive regulation of glucokinase activity </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 18 </td> <td align="center"> GO:0045338 </td> <td align="right"> 0.01 </td> <td align="right"> 199.45 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   5 </td> <td> farnesyl diphosphate metabolic process </td> <td> HMGCS2 </td> </tr>
  <tr> <td> 19 </td> <td align="center"> GO:0045820 </td> <td align="right"> 0.01 </td> <td align="right"> 199.45 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   5 </td> <td> negative regulation of glycolytic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 20 </td> <td align="center"> GO:2001235 </td> <td align="right"> 0.01 </td> <td align="right"> 17.04 </td> <td align="right"> 0.14 </td> <td align="right">   2 </td> <td align="right"> 102 </td> <td> positive regulation of apoptotic signaling pathway </td> <td> YWHAQ, RIPK3 </td> </tr>
  <tr> <td> 21 </td> <td align="center"> GO:0046951 </td> <td align="right"> 0.01 </td> <td align="right"> 132.94 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   7 </td> <td> ketone body biosynthetic process </td> <td> HMGCS2 </td> </tr>
  <tr> <td> 22 </td> <td align="center"> GO:0097151 </td> <td align="right"> 0.01 </td> <td align="right"> 132.94 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   7 </td> <td> positive regulation of inhibitory postsynaptic potential </td> <td> RIMS1 </td> </tr>
  <tr> <td> 23 </td> <td align="center"> GO:1900372 </td> <td align="right"> 0.01 </td> <td align="right"> 132.94 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   7 </td> <td> negative regulation of purine nucleotide biosynthetic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 24 </td> <td align="center"> GO:0060149 </td> <td align="right"> 0.01 </td> <td align="right"> 113.94 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   8 </td> <td> negative regulation of posttranscriptional gene silencing </td> <td> RMRP </td> </tr>
  <tr> <td> 25 </td> <td align="center"> GO:0060967 </td> <td align="right"> 0.01 </td> <td align="right"> 113.94 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   8 </td> <td> negative regulation of gene silencing by RNA </td> <td> RMRP </td> </tr>
  <tr> <td> 26 </td> <td align="center"> GO:1990000 </td> <td align="right"> 0.01 </td> <td align="right"> 113.94 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   8 </td> <td> amyloid fibril formation </td> <td> RIPK3 </td> </tr>
  <tr> <td> 27 </td> <td align="center"> GO:0060348 </td> <td align="right"> 0.01 </td> <td align="right"> 13.82 </td> <td align="right"> 0.17 </td> <td align="right">   2 </td> <td align="right"> 125 </td> <td> bone development </td> <td> COL12A1, COL13A1 </td> </tr>
  <tr> <td> 28 </td> <td align="center"> GO:0048535 </td> <td align="right"> 0.01 </td> <td align="right"> 99.69 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   9 </td> <td> lymph node development </td> <td> RIPK3 </td> </tr>
  <tr> <td> 29 </td> <td align="center"> GO:0051195 </td> <td align="right"> 0.01 </td> <td align="right"> 99.69 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   9 </td> <td> negative regulation of cofactor metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 30 </td> <td align="center"> GO:1903299 </td> <td align="right"> 0.01 </td> <td align="right"> 99.69 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">   9 </td> <td> regulation of hexokinase activity </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 31 </td> <td align="center"> GO:0048705 </td> <td align="right"> 0.01 </td> <td align="right"> 13.60 </td> <td align="right"> 0.17 </td> <td align="right">   2 </td> <td align="right"> 127 </td> <td> skeletal system morphogenesis </td> <td> COL12A1, COL13A1 </td> </tr>
  <tr> <td> 32 </td> <td align="center"> GO:0006000 </td> <td align="right"> 0.01 </td> <td align="right"> 88.60 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">  10 </td> <td> fructose metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 33 </td> <td align="center"> GO:0030150 </td> <td align="right"> 0.01 </td> <td align="right"> 88.60 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">  10 </td> <td> protein import into mitochondrial matrix </td> <td> DNLZ </td> </tr>
  <tr> <td> 34 </td> <td align="center"> GO:1903579 </td> <td align="right"> 0.01 </td> <td align="right"> 88.60 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">  10 </td> <td> negative regulation of ATP metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 35 </td> <td align="center"> GO:0003429 </td> <td align="right"> 0.01 </td> <td align="right"> 79.74 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">  11 </td> <td> growth plate cartilage chondrocyte morphogenesis </td> <td> COL12A1 </td> </tr>
  <tr> <td> 36 </td> <td align="center"> GO:0070920 </td> <td align="right"> 0.01 </td> <td align="right"> 79.74 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">  11 </td> <td> regulation of production of small RNA involved in gene silencing by RNA </td> <td> RMRP </td> </tr>
  <tr> <td> 37 </td> <td align="center"> GO:0090171 </td> <td align="right"> 0.01 </td> <td align="right"> 79.74 </td> <td align="right"> 0.01 </td> <td align="right">   1 </td> <td align="right">  11 </td> <td> chondrocyte morphogenesis </td> <td> COL12A1 </td> </tr>
  <tr> <td> 38 </td> <td align="center"> GO:0045821 </td> <td align="right"> 0.02 </td> <td align="right"> 72.48 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  12 </td> <td> positive regulation of glycolytic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 39 </td> <td align="center"> GO:0045980 </td> <td align="right"> 0.02 </td> <td align="right"> 72.48 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  12 </td> <td> negative regulation of nucleotide metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 40 </td> <td align="center"> GO:0006839 </td> <td align="right"> 0.02 </td> <td align="right"> 11.54 </td> <td align="right"> 0.20 </td> <td align="right">   2 </td> <td align="right"> 149 </td> <td> mitochondrial transport </td> <td> YWHAQ, DNLZ </td> </tr>
  <tr> <td> 41 </td> <td align="center"> GO:0001914 </td> <td align="right"> 0.02 </td> <td align="right"> 66.43 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  13 </td> <td> regulation of T cell mediated cytotoxicity </td> <td> RIPK3 </td> </tr>
  <tr> <td> 42 </td> <td align="center"> GO:0003433 </td> <td align="right"> 0.02 </td> <td align="right"> 66.43 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  13 </td> <td> chondrocyte development involved in endochondral bone morphogenesis </td> <td> COL12A1 </td> </tr>
  <tr> <td> 43 </td> <td align="center"> GO:0048791 </td> <td align="right"> 0.02 </td> <td align="right"> 66.43 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  13 </td> <td> calcium ion-regulated exocytosis of neurotransmitter </td> <td> RIMS1 </td> </tr>
  <tr> <td> 44 </td> <td align="center"> GO:1900740 </td> <td align="right"> 0.02 </td> <td align="right"> 66.43 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  13 </td> <td> positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway </td> <td> YWHAQ </td> </tr>
  <tr> <td> 45 </td> <td align="center"> GO:0046835 </td> <td align="right"> 0.02 </td> <td align="right"> 61.32 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  14 </td> <td> carbohydrate phosphorylation </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 46 </td> <td align="center"> GO:0051194 </td> <td align="right"> 0.02 </td> <td align="right"> 61.32 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  14 </td> <td> positive regulation of cofactor metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 47 </td> <td align="center"> GO:1903861 </td> <td align="right"> 0.02 </td> <td align="right"> 61.32 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  14 </td> <td> positive regulation of dendrite extension </td> <td> RIMS1 </td> </tr>
  <tr> <td> 48 </td> <td align="center"> GO:0001958 </td> <td align="right"> 0.02 </td> <td align="right"> 49.81 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  17 </td> <td> endochondral ossification </td> <td> COL13A1 </td> </tr>
  <tr> <td> 49 </td> <td align="center"> GO:0016056 </td> <td align="right"> 0.02 </td> <td align="right"> 49.81 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  17 </td> <td> rhodopsin mediated signaling pathway </td> <td> GNGT1 </td> </tr>
  <tr> <td> 50 </td> <td align="center"> GO:0060536 </td> <td align="right"> 0.02 </td> <td align="right"> 49.81 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  17 </td> <td> cartilage morphogenesis </td> <td> COL12A1 </td> </tr>
  <tr> <td> 51 </td> <td align="center"> GO:2000463 </td> <td align="right"> 0.02 </td> <td align="right"> 46.87 </td> <td align="right"> 0.02 </td> <td align="right">   1 </td> <td align="right">  18 </td> <td> positive regulation of excitatory postsynaptic potential </td> <td> RIMS1 </td> </tr>
  <tr> <td> 52 </td> <td align="center"> GO:0003417 </td> <td align="right"> 0.03 </td> <td align="right"> 44.27 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  19 </td> <td> growth plate cartilage development </td> <td> COL12A1 </td> </tr>
  <tr> <td> 53 </td> <td align="center"> GO:0010922 </td> <td align="right"> 0.03 </td> <td align="right"> 44.27 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  19 </td> <td> positive regulation of phosphatase activity </td> <td> RIPK3 </td> </tr>
  <tr> <td> 54 </td> <td align="center"> GO:0010939 </td> <td align="right"> 0.03 </td> <td align="right"> 44.27 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  19 </td> <td> regulation of necrotic cell death </td> <td> RIPK3 </td> </tr>
  <tr> <td> 55 </td> <td align="center"> GO:0045912 </td> <td align="right"> 0.03 </td> <td align="right"> 44.27 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  19 </td> <td> negative regulation of carbohydrate metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 56 </td> <td align="center"> GO:0051204 </td> <td align="right"> 0.03 </td> <td align="right"> 44.27 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  19 </td> <td> protein insertion into mitochondrial membrane </td> <td> YWHAQ </td> </tr>
  <tr> <td> 57 </td> <td align="center"> GO:1903580 </td> <td align="right"> 0.03 </td> <td align="right"> 44.27 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  19 </td> <td> positive regulation of ATP metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 58 </td> <td align="center"> GO:0030574 </td> <td align="right"> 0.03 </td> <td align="right"> 41.93 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  20 </td> <td> collagen catabolic process </td> <td> COL13A1 </td> </tr>
  <tr> <td> 59 </td> <td align="center"> GO:0008299 </td> <td align="right"> 0.03 </td> <td align="right"> 39.83 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  21 </td> <td> isoprenoid biosynthetic process </td> <td> HMGCS2 </td> </tr>
  <tr> <td> 60 </td> <td align="center"> GO:0048536 </td> <td align="right"> 0.03 </td> <td align="right"> 39.83 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  21 </td> <td> spleen development </td> <td> RIPK3 </td> </tr>
  <tr> <td> 61 </td> <td align="center"> GO:0042462 </td> <td align="right"> 0.03 </td> <td align="right"> 37.93 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  22 </td> <td> eye photoreceptor cell development </td> <td> GNGT1 </td> </tr>
  <tr> <td> 62 </td> <td align="center"> GO:1900373 </td> <td align="right"> 0.03 </td> <td align="right"> 37.93 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  22 </td> <td> positive regulation of purine nucleotide biosynthetic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 63 </td> <td align="center"> GO:0006084 </td> <td align="right"> 0.03 </td> <td align="right"> 36.20 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  23 </td> <td> acetyl-CoA metabolic process </td> <td> HMGCS2 </td> </tr>
  <tr> <td> 64 </td> <td align="center"> GO:0030811 </td> <td align="right"> 0.03 </td> <td align="right"> 36.20 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  23 </td> <td> regulation of nucleotide catabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 65 </td> <td align="center"> GO:1901028 </td> <td align="right"> 0.03 </td> <td align="right"> 36.20 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  23 </td> <td> regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway </td> <td> YWHAQ </td> </tr>
  <tr> <td> 66 </td> <td align="center"> GO:0097300 </td> <td align="right"> 0.03 </td> <td align="right"> 34.63 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  24 </td> <td> programmed necrotic cell death </td> <td> RIPK3 </td> </tr>
  <tr> <td> 67 </td> <td align="center"> GO:0098868 </td> <td align="right"> 0.03 </td> <td align="right"> 34.63 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  24 </td> <td> bone growth </td> <td> COL12A1 </td> </tr>
  <tr> <td> 68 </td> <td align="center"> GO:0032094 </td> <td align="right"> 0.03 </td> <td align="right"> 33.18 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  25 </td> <td> response to food </td> <td> SLC16A1 </td> </tr>
  <tr> <td> 69 </td> <td align="center"> GO:0035987 </td> <td align="right"> 0.03 </td> <td align="right"> 33.18 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  25 </td> <td> endodermal cell differentiation </td> <td> COL12A1 </td> </tr>
  <tr> <td> 70 </td> <td align="center"> GO:2001169 </td> <td align="right"> 0.03 </td> <td align="right"> 33.18 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  25 </td> <td> regulation of ATP biosynthetic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 71 </td> <td align="center"> GO:0030199 </td> <td align="right"> 0.03 </td> <td align="right"> 31.85 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  26 </td> <td> collagen fibril organization </td> <td> COL12A1 </td> </tr>
  <tr> <td> 72 </td> <td align="center"> GO:0043470 </td> <td align="right"> 0.03 </td> <td align="right"> 31.85 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  26 </td> <td> regulation of carbohydrate catabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 73 </td> <td align="center"> GO:0045981 </td> <td align="right"> 0.03 </td> <td align="right"> 31.85 </td> <td align="right"> 0.03 </td> <td align="right">   1 </td> <td align="right">  26 </td> <td> positive regulation of nucleotide metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 74 </td> <td align="center"> GO:0060350 </td> <td align="right"> 0.03 </td> <td align="right"> 31.71 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  28 </td> <td> endochondral bone morphogenesis </td> <td> COL12A1 </td> </tr>
  <tr> <td> 75 </td> <td align="center"> GO:0021762 </td> <td align="right"> 0.04 </td> <td align="right"> 29.49 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  28 </td> <td> substantia nigra development </td> <td> YWHAQ </td> </tr>
  <tr> <td> 76 </td> <td align="center"> GO:0031050 </td> <td align="right"> 0.04 </td> <td align="right"> 29.49 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  28 </td> <td> dsRNA processing </td> <td> RMRP </td> </tr>
  <tr> <td> 77 </td> <td align="center"> GO:0046006 </td> <td align="right"> 0.04 </td> <td align="right"> 28.43 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  29 </td> <td> regulation of activated T cell proliferation </td> <td> RIPK3 </td> </tr>
  <tr> <td> 78 </td> <td align="center"> GO:0010659 </td> <td align="right"> 0.04 </td> <td align="right"> 26.53 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  31 </td> <td> cardiac muscle cell apoptotic process </td> <td> GNGT1 </td> </tr>
  <tr> <td> 79 </td> <td align="center"> GO:0043029 </td> <td align="right"> 0.04 </td> <td align="right"> 26.53 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  31 </td> <td> T cell homeostasis </td> <td> RIPK3 </td> </tr>
  <tr> <td> 80 </td> <td align="center"> GO:0045123 </td> <td align="right"> 0.04 </td> <td align="right"> 26.53 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  31 </td> <td> cellular extravasation </td> <td> RIPK3 </td> </tr>
  <tr> <td> 81 </td> <td align="center"> GO:0048538 </td> <td align="right"> 0.04 </td> <td align="right"> 25.67 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  32 </td> <td> thymus development </td> <td> RIPK3 </td> </tr>
  <tr> <td> 82 </td> <td align="center"> GO:0051196 </td> <td align="right"> 0.04 </td> <td align="right"> 25.67 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  32 </td> <td> regulation of coenzyme metabolic process </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 83 </td> <td align="center"> GO:0070231 </td> <td align="right"> 0.04 </td> <td align="right"> 25.67 </td> <td align="right"> 0.04 </td> <td align="right">   1 </td> <td align="right">  32 </td> <td> T cell apoptotic process </td> <td> RIPK3 </td> </tr>
  <tr> <td> 84 </td> <td align="center"> GO:0043062 </td> <td align="right"> 0.04 </td> <td align="right"> 6.75 </td> <td align="right"> 0.34 </td> <td align="right">   2 </td> <td align="right"> 251 </td> <td> extracellular structure organization </td> <td> COL12A1, COL13A1 </td> </tr>
  <tr> <td> 85 </td> <td align="center"> GO:0033762 </td> <td align="right"> 0.04 </td> <td align="right"> 24.11 </td> <td align="right"> 0.05 </td> <td align="right">   1 </td> <td align="right">  34 </td> <td> response to glucagon </td> <td> PFKFB1 </td> </tr>
  <tr> <td> 86 </td> <td align="center"> GO:0070228 </td> <td align="right"> 0.04 </td> <td align="right"> 24.11 </td> <td align="right"> 0.05 </td> <td align="right">   1 </td> <td align="right">  34 </td> <td> regulation of lymphocyte apoptotic process </td> <td> RIPK3 </td> </tr>
  <tr> <td> 87 </td> <td align="center"> GO:0051353 </td> <td align="right"> 0.05 </td> <td align="right"> 23.40 </td> <td align="right"> 0.05 </td> <td align="right">   1 </td> <td align="right">  35 </td> <td> positive regulation of oxidoreductase activity </td> <td> RIPK3 </td> </tr>
  <tr> <td> 88 </td> <td align="center"> GO:1902110 </td> <td align="right"> 0.05 </td> <td align="right"> 22.73 </td> <td align="right"> 0.05 </td> <td align="right">   1 </td> <td align="right">  36 </td> <td> positive regulation of mitochondrial membrane permeability involved in apoptotic process </td> <td> YWHAQ </td> </tr>
  <tr> <td> 89 </td> <td align="center"> GO:0007275 </td> <td align="right"> 0.05 </td> <td align="right"> 2.70 </td> <td align="right"> 4.47 </td> <td align="right">   8 </td> <td align="right"> 3331 </td> <td> multicellular organism development </td> <td> COL12A1, COL13A1, GNGT1, PFKFB1, YWHAQ, RIPK3, RIMS1, SHISA3 </td> </tr>
  <tr> <td> 90 </td> <td align="center"> GO:0006091 </td> <td align="right"> 0.05 </td> <td align="right"> 6.36 </td> <td align="right"> 0.36 </td> <td align="right">   2 </td> <td align="right"> 266 </td> <td> generation of precursor metabolites and energy </td> <td> HMGCS2, PFKFB1 </td> </tr>
  <tr> <td> 91 </td> <td align="center"> GO:0006977 </td> <td align="right"> 0.05 </td> <td align="right"> 21.50 </td> <td align="right"> 0.05 </td> <td align="right">   1 </td> <td align="right">  38 </td> <td> DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest </td> <td> PCBP4 </td> </tr>
   </table>
